Austin Argentieri @ 2024 Biomarkers of Aging Conference

Описание: Austin Argentieri emphasizes the importance of developing simple, cost-effective proteomic aging biomarkers for preventative medicine. He highlights the need for generalizable aging clocks that predict future disease and frailty risks, leverage genetic data, and are modifiable to enhance healthspan.

Timestamps
[00:00:32] Age-related diseases are major killers globally
[00:01:17] Aging biomarkers for preventative health
[00:01:45] Developing generalizable aging clocks
[00:03:35] Aging biomarkers: the simpler the better; reduced complexity = reduced cost
[00:04:36] Aging biomarkers should capture the future risk of disease and frailty before onset
[00:07:06] Leveraging genetic information to improve confidence in biomarkers
[00:09:09] Aging biomarkers should be modfiable
[00:10:17] Levers to improve healthspan

Austin Argentieri is a researcher in the Analytic and Translational Genetics Unit at Massachusetts General Hospital, with academic appointments at Harvard Medical School and the Broad Institute. He is also a member of the Center for Genomic Medicine at Massachusetts General Hospital. With a PhD and postdoctoral research experience from the Big Data Institute at the University of Oxford, his work focuses on large-scale analyses to uncover the genetic, biological, and environmental determinants of human aging and age-related diseases.

Thank you XPRIZE Healthspan for your support during this session! Learn more about XPRIZE Healthspan: https://www.xprize.org/prizes/healthspan

And thanks to Firuza Foundation for supporting Austin's talk as well. Learn more about Firuza Foundation: https://www.firuzafoundation.org/